Differanisole_NN
A_NN
,_,
a_DT
novel_JJ
antitumor_JJ
antibiotic_NN
,_,
enhances_VBZ
growth_NN
inhibition_NN
and_CC
differentiation_NN
of_IN
human_JJ
myeloid_JJ
leukemia_NN
cells_NNS
induced_VBN
by_IN
9-cis_JJ
retinoic_JJ
acid_NN
._.

Differanisole_NN
A_NN
,_,
3,5-dichloro-2-hydroxy-4-methoxy-6-n-propylbenzoic_JJ
acid_NN
,_,
inhibited_VBD
growth_NN
of_IN
human_JJ
myeloid_JJ
leukemia_NN
cells_NNS
._.

The_DT
compound_NN
induced_VBD
G1_NN
arrest_NN
and_CC
granulocytic_JJ
differentiation_NN
of_IN
HL-60_NN
cells_NNS
,_,
although_IN
the_DT
differentiation-inducing_JJ
effect_NN
was_VBD
modest_JJ
._.

Differanisole_NN
A_NN
and_CC
9-cis_JJ
retinoic_JJ
acid_NN
-LRB-_-LRB-
9cisRA_NN
-RRB-_-RRB-
synergistically_RB
inhibited_VBD
the_DT
growth_NN
and_CC
induced_VBD
functional_JJ
and_CC
morphologic_JJ
differentiation_NN
of_IN
HL-60_NN
and_CC
NB4_NN
cells_NNS
,_,
whereas_IN
the_DT
combined_JJ
treatment_NN
with_IN
differanisole_NN
A_NN
and_CC
all-trans_JJ
retinoic_JJ
acid_NN
or_CC
1alpha,25-dihydroxyvitamin_NN
D3_NN
was_VBD
less_RBR
effective_JJ
._.

Similar_JJ
results_NNS
were_VBD
obtained_VBN
in_IN
primary_JJ
culture_NN
of_IN
leukemia_NN
cells_NNS
from_IN
a_DT
patient_NN
with_IN
acute_JJ
promyelocytic_JJ
leukemia_NN
._.

The_DT
synergistic_JJ
effect_NN
on_IN
growth_NN
inhibition_NN
and_CC
induction_NN
of_IN
differentiation_NN
required_VBD
simultaneous_JJ
treatment_NN
with_IN
differanisole_NN
A_NN
and_CC
9cisRA_NN
._.

Differanisole_NN
A_NN
and_CC
an_DT
RXR-specific_JJ
ligand_NN
-LRB-_-LRB-
Ro47-5944_NN
-RRB-_-RRB-
cooperatively_RB
inhibited_VBD
the_DT
cell_NN
growth_NN
,_,
while_IN
the_DT
combined_JJ
effect_NN
of_IN
differanisole_NN
A_NN
and_CC
an_DT
RAR-specific_JJ
ligand_NN
Am80_NN
was_VBD
just_RB
additive_JJ
._.

Differanisole_NN
A_NN
in_IN
combination_NN
with_IN
9cisRA_NN
may_MD
have_VB
implications_NNS
for_IN
therapy_NN
of_IN
acute_JJ
promyelocytic_JJ
leukemia_NN
patients_NNS
._.

